These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23302874)

  • 1. Efavirenz enhances HIV-1 gag processing at the plasma membrane through Gag-Pol dimerization.
    Sudo S; Haraguchi H; Hirai Y; Gatanaga H; Sakuragi J; Momose F; Morikawa Y
    J Virol; 2013 Mar; 87(6):3348-60. PubMed ID: 23302874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
    Hsieh SH; Yu FH; Huang KJ; Wang CT
    J Virol; 2023 Sep; 97(9):e0094823. PubMed ID: 37671867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations at human immunodeficiency virus type 1 reverse transcriptase tryptophan repeat motif attenuate the inhibitory effect of efavirenz on virus production.
    Chiang CC; Wang SM; Tseng YT; Huang KJ; Wang CT
    Virology; 2009 Jan; 383(2):261-70. PubMed ID: 19019404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation.
    Tachedjian G; Moore KL; Goff SP; Sluis-Cremer N
    FEBS Lett; 2005 Jan; 579(2):379-84. PubMed ID: 15642347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag.
    Popov S; Strack B; Sanchez-Merino V; Popova E; Rosin H; Göttlinger HG
    J Virol; 2011 Apr; 85(8):3792-801. PubMed ID: 21289110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.
    Figueiredo A; Moore KL; Mak J; Sluis-Cremer N; de Bethune MP; Tachedjian G
    PLoS Pathog; 2006 Nov; 2(11):e119. PubMed ID: 17096588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers.
    Braz VA; Holladay LA; Barkley MD
    Biochemistry; 2010 Jan; 49(3):601-10. PubMed ID: 20039714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag-to-GagPol ratio.
    Haraguchi H; Sudo S; Noda T; Momose F; Kawaoka Y; Morikawa Y
    Microbiol Immunol; 2010 Dec; 54(12):734-46. PubMed ID: 21091985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonnucleoside reverse transcriptase inhibitor-resistant HIV is stimulated by efavirenz during early stages of infection.
    Wang J; Zhang G; Bambara RA; Li D; Liang H; Wu H; Smith HM; Lowe NR; Demeter LM; Dykes C
    J Virol; 2011 Oct; 85(20):10861-73. PubMed ID: 21835788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
    Lee SK; Potempa M; Kolli M; Özen A; Schiffer CA; Swanstrom R
    J Biol Chem; 2012 Apr; 287(16):13279-90. PubMed ID: 22334652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag.
    Yu FH; Huang KJ; Wang CT
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31906562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large extension to HIV-1 Gag, like Pol, has negative impacts on virion assembly.
    Haraguchi H; Noda T; Kawaoka Y; Morikawa Y
    PLoS One; 2012; 7(10):e47828. PubMed ID: 23110110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the nucleocapsid domain in HIV-1 Gag oligomerization and trafficking to the plasma membrane: a fluorescence lifetime imaging microscopy investigation.
    El Meshri SE; Dujardin D; Godet J; Richert L; Boudier C; Darlix JL; Didier P; Mély Y; de Rocquigny H
    J Mol Biol; 2015 Mar; 427(6 Pt B):1480-1494. PubMed ID: 25644662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study.
    Feng JY; Ly JK; Myrick F; Goodman D; White KL; Svarovskaia ES; Borroto-Esoda K; Miller MD
    Retrovirology; 2009 May; 6():44. PubMed ID: 19439089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.
    Pan YY; Wang SM; Huang KJ; Chiang CC; Wang CT
    PLoS One; 2012; 7(3):e32845. PubMed ID: 22396796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent manner.
    Lee YM; Tian CJ; Yu XF
    J Virol; 1998 Nov; 72(11):9061-8. PubMed ID: 9765451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of multimerization on membrane association of Rous sarcoma virus and HIV-1 matrix domain proteins.
    Dick RA; Kamynina E; Vogt VM
    J Virol; 2013 Dec; 87(24):13598-608. PubMed ID: 24109216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
    Yu FH; Huang KJ; Wang CT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.